cyc 202 has been researched along with Carcinoma, Non-Small Cell Lung in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, RX; Liu, JL; Wu, G; Zhou, FZ; Zhou, XS | 1 |
| Chia, DM; Chinnathambi, A; Goh, BC; Ho, PC; Kong, LR; Lau, JY; Ong, PS; Seah, JY; Sethi, G; Thuya, WL; Wang, L; Wong, AL; Yang, D; Yong, WP | 1 |
| Cheng, QS; Gu, ZP; Han, Y; Li, XF; Mei, QB; Wang, XP; Zhang, F; Zhang, T; Zhou, YA | 1 |
| Jiang, T; Li, C; Li, XF; Zhang, F; Zhang, T; Zhou, YA; Zhu, YF | 1 |
| Slovackova, J; Smarda, J; Smardova, J | 1 |
| Henfling, ME; Ramaekers, FC; Schutte, B | 1 |
| Cress, WD; Freeman, SN; Ma, Y | 1 |
| Kuijpers, HJ; Ramaekers, FC; Reutelingsperger, CP; Schutte, B; van Engeland, M | 1 |
| Henfling, ME; Meijer, L; Nieland, L; Ramaekers, FC; Schutte, B; van Engeland, M | 1 |
| Chang, TH; Lee, HR; Senderowicz, AM; Szabo, E; Tebalt, MJ | 1 |
10 other study(ies) available for cyc 202 and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Cyclin-dependent kinase 5 regulates the proliferation, motility and invasiveness of lung cancer cells through its effects on cytoskeletal remodeling.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinase 5; Cytoskeleton; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Microvilli; Purines; Real-Time Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Roscovitine | 2015 |
A novel combinatorial strategy using Seliciclib(®) and Belinostat(®) for eradication of non-small cell lung cancer via apoptosis induction and BID activation.
Topics: A549 Cells; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspase 8; Caspase Inhibitors; Cell Proliferation; Dose-Response Relationship, Drug; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Inhibitory Concentration 50; Lung Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Purines; RNA Interference; Roscovitine; Signal Transduction; Sulfonamides; Time Factors; Transfection; Tumor Suppressor Protein p53; X-Linked Inhibitor of Apoptosis Protein | 2016 |
Enhancement of radiosensitivity by roscovitine pretreatment in human non-small cell lung cancer A549 cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Humans; Purines; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; Roscovitine | 2008 |
Involvement of p21Waf1/Cip1 cleavage during roscovitine-induced apoptosis in non-small cell lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase Inhibitors; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; DNA Repair; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Histones; Humans; Lung Neoplasms; Purines; Roscovitine | 2010 |
Roscovitine-induced apoptosis of H1299 cells depends on functional status of p53.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Humans; Lung Neoplasms; Purines; Roscovitine; Tumor Suppressor Protein p53 | 2012 |
Proteasomes act in the pre-mitochondrial signal transduction route towards roscovitine-induced apoptosis.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cysteine Proteinase Inhibitors; Humans; Leupeptins; Lung Neoplasms; Membrane Potentials; Mitochondria; Proteasome Endopeptidase Complex; Purines; Roscovitine; Signal Transduction; Tumor Cells, Cultured | 2004 |
E2F4 deficiency promotes drug-induced apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; E2F4 Transcription Factor; Fibroblasts; Flavonoids; Humans; Lung Neoplasms; Mice; Mice, Knockout; Oxazoles; Piperidines; Protein Kinase Inhibitors; Purines; RNA, Small Interfering; Roscovitine; Thiazoles; Transcription Factors; Tumor Cells, Cultured | 2004 |
Plasma membrane alterations and cytoskeletal changes in apoptosis.
Topics: Actins; Annexin A5; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Membrane; Chromatin; Cytoskeleton; Ethylmaleimide; Humans; Keratins; Kinetin; Lung Neoplasms; Neuroblastoma; Phosphatidylserines; Purines; Roscovitine; Tetradecanoylphorbol Acetate; Tubulin; Tumor Cells, Cultured; Vimentin | 1997 |
The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
Topics: Antimetabolites; Apoptosis; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; CDC2 Protein Kinase; Cell Cycle; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; G2 Phase; Humans; Kinetin; Lung Neoplasms; Mitosis; Neuroblastoma; Purines; Roscovitine; S Phase; Tumor Cells, Cultured | 1997 |
Induction of differentiation accompanies inhibition of Cdk2 in a non-small cell lung cancer cell line.
Topics: Carcinoma, Non-Small-Cell Lung; CDC2-CDC28 Kinases; Cell Differentiation; Cell Division; Cyclin D; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Cyclins; Enzyme Inhibitors; Flavonoids; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Neoplasm Proteins; Piperidines; Protein Serine-Threonine Kinases; Purines; Roscovitine; Signal Transduction; Transfection; Tumor Cells, Cultured | 1999 |